awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38975736-208CF4D6-4FDA-4640-A2A1-89B232F77A8A
Q38975736-208CF4D6-4FDA-4640-A2A1-89B232F77A8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38975736-208CF4D6-4FDA-4640-A2A1-89B232F77A8A
Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.
P2860
Q38975736-208CF4D6-4FDA-4640-A2A1-89B232F77A8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38975736-208CF4D6-4FDA-4640-A2A1-89B232F77A8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c6f55fdbb11150b044ffb61054e3f2992e0701e
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.